BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• 

  FDA

  ALS Update: FDA Sets Amylyx Date, Roche and Aquinnah Collaborate

  The FDA will evaluate AMX0035, an investigational oral fixed-dose drug intended for people diagnosed with ALS.

  February 17, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Biotech Bay

  What BioSpace Heard at the BIO CEO & Investor Conference

  BioSpace learned that growing functional organs may indeed be possible, and about the role of protein-to-protein interactions in cancer immunotherapy.

  February 17, 2022

   · 

  4 min read

   · 

  Gail Dutton
• 

  Drug Development

  Additional Deaths of Patients Taking Aduhelm Spark Renewed Concern

  It’s not clear if the recent deaths reported in FAERS resulted from the patients taking Aduhelm. This article takes a deep dive into this controversy.

  February 17, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  Startup Remix Inks RNA Collab with Janssen Valued at $1B

  The strategic collaboration centers on Remix’s REMaster platform for the discovery and development of small molecule therapies that modulate RNA processing.

  February 17, 2022

   · 

  4 min read

   · 

  Alex Keown
• 

  Policy

  COVID-19 Update: 73% of Americans Likely Immune to Omicron

  At this time, 73% of Americans are immune to Omicron, and it could rise to 80% by mid-March. For that and more COVID-19 news, continue reading.

  February 17, 2022

   · 

  4 min read

   · 

  Mark Terry
• 

  Drug Development

  Despite Robust Results, Innovent Cholesterol Drug Could Face U.S. Challenges

  By the end of the CREDIT-1 study, patients experienced a significant reduction in low-density lipoprotein cholesterol compared to the placebo group.

  February 17, 2022

   · 

  3 min read

   · 

  Hannah Chudleigh
• 

  Business

  BioSpace Movers & Shakers, Feb. 18

  Biopharma and life sciences organizations strengthen their leadership teams and boards with these Movers & Shakers.

  February 17, 2022

   · 

  9 min read

   · 

  Alex Keown
• 

  Business

  On the Bubble, Yumanity Announces Layoffs of 60% of Staff

  In addition to massive layoffs – around 60% of its workforce – Yumanity also said it is considering “strategic alternatives” to its financial woes, including the possibility of selling or merging.

  February 17, 2022

   · 

  2 min read

   · 

  Hannah Chudleigh
• 

  Drug Development

  Research Roundup: All About Antibodies and a Neuroprotective Enzyme

  Research Roundup for February 18

  February 17, 2022

   · 

  6 min read

   · 

  Mark Terry
• 

  Drug Development

  Scientists: High Estrogen Levels, Antacids May Reduce COVID-19 Risk

  Researchers found that augmenting estrogen levels in postmenopausal women who had tested positive for SARS-CoV-2 might help reduce one’s risk of death from COVID-19.

  February 17, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, RN